Arpeggio Biosciences
PrivateLast Round
Series B
Nov 25, 2025
Est. Valuation
$2.14M
Total Funding Raised
$24.38M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arpeggio Biosciences is a biotechnology company that develops a drug assessment technology platform combining proprietary biological assays and machine learning to provide insights into cellular dynamics and identify new drug targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arpeggio Biosciences Comparables
Compare Arpeggio Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcripta Bio | 84% | |
| Phenomic AI | 79% | |
| Alithea Genomics | 77% |
Arpeggio Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 25, 2025 | ||||
| Series A Extension | Jan 30, 2024 | ||||
| Series A | Sep 7, 2022 | ||||
| Seed | Jan 15, 2020 | ||||
| Accelerator | Aug 16, 2019 |
Key People
Founding team and executive leadership
Arpeggio Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Builders VC | Series A |
| Khosla Ventures | Series A, Seed |
| Tau Ventures | Series A |
| BoxOne Ventures | Series A |
| Y Combinator | Seed, Accelerator |
| FundersClub | Series A, Seed |
| ATEM Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 214% MoM.
- Nov 25, 2025
$20M round completed.
Arpeggio Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arpeggio Biosciences's valuation, stock price, and market status.
Is Arpeggio a public or private company?
Arpeggio is a private company.
What is the current stock price of Arpeggio?
Arpeggio is a private company with no public stock price. No recent secondary market data is available.
How much is Arpeggio worth (valuation)?
Arpeggio's valuation is estimated at $2.1M based on funding round data.
Can I buy Arpeggio stock?
Arpeggio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arpeggio's last funding round?
Arpeggio's most recent funding round was Series A Extension on August 16, 2019.
Who are the main investors in Arpeggio?
Key investors in Arpeggio include Builders VC, Khosla Ventures, Y Combinator.
Will Arpeggio IPO soon?
No public IPO plans have been announced for Arpeggio.
How can I track Arpeggio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arpeggio's secondary market activity and sign up for updates.